| P50 | author | Gina Samaan | Q63245084 |
| P2093 | author name string | Jeffrey Partridge | |
| | Michelle McPherson | |
| P2860 | cites work | Health policy and systems research agendas in developing countries | Q24801146 |
| | Influenza-associated hospitalization in a subtropical city | Q25256617 |
| | Willingness to accept H1N1 pandemic influenza vaccine: a cross-sectional study of Hong Kong community nurses. | Q30226919 |
| | Cost-effectiveness study on influenza prevention in Hong Kong. | Q30328288 |
| | Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. | Q30342052 |
| | The macro-epidemiology of influenza vaccination in 56 countries, 1997--2003. | Q30351091 |
| | Removing barriers to global pandemic influenza vaccination. | Q30355074 |
| | Influenza surveillance and immunisation in New Zealand, 1997-2006. | Q30377231 |
| | Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. | Q30379479 |
| | Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults. | Q30379899 |
| | Cross-sectional and longitudinal factors predicting influenza vaccination in Hong Kong Chinese elderly aged 65 and above | Q43175648 |
| | On-site influenza vaccination arrangements improved influenza vaccination rate of employees of a tertiary hospital in Singapore | Q43176031 |
| | Cost-effectiveness analysis of influenza vaccination for people aged 65 and over in Japan | Q43176072 |
| | Influenza vaccine coverage rates and perceptions on vaccination in South Korea | Q43176122 |
| | Prevalence of influenza vaccination and correlates of intention to be vaccinated among Hong Kong Chinese | Q43176593 |
| | Gargling with tea catechin extracts for the prevention of influenza infection in elderly nursing home residents: a prospective clinical study | Q43176648 |
| | Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan. | Q43176738 |
| | Effectiveness of influenza vaccination in preventing influenza-like illness among community-dwelling elderly: population-based cohort study in Japan | Q43176859 |
| | Prevalence of influenza vaccination and associated factors among community-dwelling Hong Kong residents of age 65 or above. | Q43176861 |
| | Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in Japan | Q43177217 |
| | Policy evaluation for the subsidy for influenza vaccination in elderly | Q43177420 |
| | Vaccine effectiveness for influenza in the elderly in welfare nursing homes during an influenza A (H3N2) epidemic | Q43209455 |
| | The Japanese experience with vaccinating schoolchildren against influenza | Q43209480 |
| | Efficacy of Influenza Vaccine in Elderly Persons in Welfare Nursing Homes: Reduction in Risks of Mortality and Morbidity During an Influenza A (H3N2) Epidemic | Q43209531 |
| | Evaluation of a mass influenza vaccination campaign. | Q43209620 |
| | Influenza in Singapore: assessing the burden of illness in the community. | Q43209661 |
| | Influenza-related hospitalizations among children in Hong Kong. | Q43209736 |
| | Influence of family on acceptance of influenza vaccination among Japanese patients | Q43209767 |
| | A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001–2002 influenza season | Q43210853 |
| | Influenza vaccination for severely multiply handicapped persons/children in the 2005-2006 season | Q44456118 |
| | The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia | Q44479748 |
| | Effectiveness and safety of inactivated influenza vaccination in pediatric liver transplant recipients over three influenza seasons | Q44822218 |
| | Cost-effectiveness of influenza vaccination of people aged 50-64 years in Australia: results are inconclusive | Q45358167 |
| | Co-administration of l-cystine and l-theanine enhances efficacy of influenza vaccination in elderly persons: nutritional status-dependent immunogenicity | Q46159582 |
| | The burden of influenza in healthy children in South Australia. | Q46402155 |
| | Prevalence of antibodies against A and B influenza viruses in South-Western Papua New Guinea | Q46713673 |
| | Co-ordinated approach to healthcare worker influenza vaccination in an area health service | Q57193916 |
| | Active influenza immunization in hemodialysis patients: comparison between single-dose and booster vaccination | Q57213178 |
| | Trends in influenza immunisation amongst an elderly Australian community | Q61864558 |
| | Prevalence of influenza vaccination in South Australian aged care homes | Q61864560 |
| | Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people | Q61911788 |
| | Poor health care worker vaccination coverage and knowledge of vaccination recommendations in a tertiary Australia hospital | Q77766765 |
| | Influenza immunisation rate for 2005 and factors associated with receiving this vaccine in patients aged 65 years and over admitted to a general medical ward at Auckland City Hospital | Q79298212 |
| | Effect of mass immunization against influenza encephalopathy on mortality rates in children | Q79338490 |
| | Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination | Q81151870 |
| | Serum immunoglobulin levels do not affect antibody responses to influenza HA vaccine in preterm infants | Q81569116 |
| | Knowledge and attitudes about influenza vaccination amongst general practitioners, practice nurses, and people aged 65 and over | Q81735300 |
| | Flutracking provides a measure of field influenza vaccine effectiveness, Australia, 2007–2009 | Q84790633 |
| | Aetiology of community-acquired pneumonia in hospitalized adult patients in New Caledonia | Q85212482 |
| | Vaccines against influenza WHO position paper – November 2012 | Q85607288 |
| | H5N1 influenza vaccination policy in Japan | Q43175055 |
| | 2005 and 2006 seasonal influenza vaccination coverage rates in 10 countries in Africa, Asia Pacific, Europe, Latin America and the Middle East | Q43175063 |
| | Differences in clinical manifestations of influenza-associated encephalopathy by age. | Q43175088 |
| | What factors affect influenza vaccine uptake among community-dwelling older Chinese people in Hong Kong general outpatient clinics? | Q43175136 |
| | Rate of influenza vaccination and its adverse reactions seen in health care personnel in a single tertiary hospital in Korea. | Q43175285 |
| | Chinese older people in Hong Kong: health beliefs about influenza vaccination | Q43175372 |
| | Effects of school closures, 2008 winter influenza season, Hong Kong. | Q43175387 |
| | Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China | Q43175540 |
| | Ecological fallacy and scepticism about influenza vaccine efficacy in Japan: the Maebashi study | Q43175564 |
| | Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. | Q30380132 |
| | Economic analysis of pandemic influenza vaccination strategies in Singapore. | Q30380974 |
| | Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey | Q30381999 |
| | Influenza excess mortality from 1950-2000 in tropical Singapore. | Q30383133 |
| | Cost-effectiveness analysis of hospital infection control response to an epidemic respiratory virus threat | Q30383186 |
| | Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. | Q30383576 |
| | Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. | Q30383723 |
| | Hospitalizations for pandemic (H1N1) 2009 among Maori and Pacific Islanders, New Zealand | Q30383856 |
| | Pandemic (H1N1) 2009 surveillance and prevalence of seasonal influenza, Singapore | Q30383859 |
| | Prevention of nosocomial transmission of swine-origin pandemic influenza virus A/H1N1 by infection control bundle. | Q30384224 |
| | Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies. | Q30385048 |
| | Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic | Q30385394 |
| | Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine | Q30388223 |
| | Disproportionate impact of pandemic (H1N1) 2009 influenza on Indigenous people in the Top End of Australia's Northern Territory. | Q30389285 |
| | Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets | Q30389462 |
| | Evaluation of vaccination strategies to suppress a novel influenza pandemic using an individual-based model | Q30389770 |
| | Perceptions and behaviors related to hand hygiene for the prevention of H1N1 influenza transmission among Korean university students during the peak pandemic period | Q30391891 |
| | Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. | Q30392786 |
| | Effectiveness of public health measures in mitigating pandemic influenza spread: a prospective sero-epidemiological cohort study | Q30394039 |
| | Clinical and immunological characteristics of patients with 2009 pandemic influenza A (H1N1) virus infection after vaccination | Q30394365 |
| | Pandemic (H1N1) 2009 influenza vaccine uptake in pregnant women entering the 2010 influenza season in Western Australia. | Q30394484 |
| | Immunogenicity and safety of a novel AS03(A)-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in Japan | Q30395352 |
| | Immunogenicity and safety of influenza A (H1N1) 2009 monovalent inactivated split vaccine in Korea. | Q30395949 |
| | Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong | Q30396064 |
| | The impact of case diagnosis coverage and diagnosis delays on the effectiveness of antiviral strategies in mitigating pandemic influenza A/H1N1 2009 | Q30396179 |
| | Annual report: surveillance of adverse events following immunisation in Australia, 2009 | Q30396460 |
| | Immunogenicity of a monovalent pandemic influenza A H1N1 vaccine in health-care workers of a university hospital in Japan | Q30396820 |
| | Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans | Q30396990 |
| | Impact of pandemic (H1N1) 2009 on Australasian critical care units | Q30397175 |
| | Estimates of the impact of a future influenza pandemic in China | Q30401469 |
| | Assessing disease burden of respiratory disorders in Hong Kong children with hospital discharge data and linked laboratory data. | Q31108020 |
| | Optimizing use of multistream influenza sentinel surveillance data. | Q31161307 |
| | Is exercise protective against influenza-associated mortality? | Q33332112 |
| | Estimation of influenza vaccine effectiveness from routine surveillance data | Q33424462 |
| | Seasonal effects of influenza on mortality in a subtropical city | Q33495707 |
| | Influenza vaccine preference and uptake among older people in nine countries. | Q33665240 |
| | Evidence-based tool for triggering school closures during influenza outbreaks, Japan | Q33800701 |
| | Immunogenicity associated with the routine use of an influenza A H1N1 vaccine in health care personnel in Guangzhou, China | Q34150347 |
| | The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over | Q34321560 |
| | Influenza-associated deaths in tropical Singapore | Q35801641 |
| | Influenza related hospitalisations in Sydney, New South Wales, Australia. | Q36153678 |
| | Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children | Q37086288 |
| | Attitudes amongst Australian hospital healthcare workers towards seasonal influenza and vaccination. | Q37087777 |
| | Annual influenza vaccination: coverage and attitudes of primary care staff in Australia | Q37087917 |
| | History of influenza vaccination programs in Japan | Q37198097 |
| | Survivors of childhood cancer: an Australian audit of vaccination status after treatment | Q37604213 |
| | Prevalence of influenza vaccination and associated factors among pregnant women in Hong Kong | Q37764535 |
| | Clinical characteristics of Korean pediatric patients critically ill with influenza A (H1N1) virus | Q37774609 |
| | Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers. | Q38479164 |
| | Major causes of death among men and women in China | Q39061262 |
| | The efficacy of influenza vaccination in healthcare workers in a tropical setting: a prospective investigator blinded observational study | Q39133852 |
| | Influenza-related deaths and hospitalizations in Hong Kong: a subtropical area | Q39174723 |
| | Viral respiratory tract infections among patients with acute undifferentiated fever in Vietnam | Q39354817 |
| | Viral agents responsible for febrile respiratory illnesses among military recruits training in tropical Singapore | Q39442543 |
| | Incidence of common respiratory viral infections related to climate factors in hospitalized children in Hong Kong | Q39509530 |
| | Influenza-associated mortality in Hong Kong | Q39601092 |
| | Does subsidy work? Price elasticity of demand for influenza vaccination among the elderly in Japan | Q39872060 |
| | A preliminary study on the medical expenditure of Chinese medicine and integrative medicine treatment for influenza a (H1N1) in the fever clinics | Q40342430 |
| | Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan | Q40354705 |
| | Influenza vaccination amongst hospital health care workers in Beijing | Q40360446 |
| | Influenza-related hospitalisations in children | Q40376140 |
| | Inactivated influenza vaccine effectiveness against influenza-like illness among young children in Japan--with special reference to minimizing outcome misclassification | Q40378753 |
| | Sole supply of influenza vaccine: economic common sense or a disaster waiting to happen? | Q40400824 |
| | Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia | Q40446038 |
| | Efficacy of inactivated trivalent influenza vaccine in alleviating the febrile illness of culture-confirmed influenza in children in the 2000-2001 influenza season | Q40484176 |
| | Retrospective assessment of influenza vaccine effectiveness among the non-institutionalized elderly population in Japan. | Q40488410 |
| | Underlying Medical Conditions and Hospitalization for Pandemic (H1N1) 2009, Japan | Q42601326 |
| | Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. | Q43173602 |
| | Comparison of the incidence of influenza in relation to climate factors during 2000-2007 in five countries | Q43173630 |
| | Influenza and seasonal influenza vaccination among diabetics in Singapore: knowledge, attitudes and practices | Q43173669 |
| | Fear Appeals and Public Service Advertising: Applications to Influenza in Hong Kong | Q43173673 |
| | High direct healthcare costs of patients hospitalised with pandemic (H1N1) 2009 influenza in Malaysia | Q43173761 |
| | Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009. | Q43173789 |
| | Influenza vaccine effectiveness in primary school children in Japan: a prospective cohort study using rapid diagnostic test results | Q43174069 |
| | Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years | Q43174580 |
| | Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong. | Q43174741 |
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | public domain | Q19652 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | influenza vaccine | Q383260 |
| P304 | page(s) | e70003 | |
| P577 | publication date | 2013-07-16 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A review of the evidence to support influenza vaccine introduction in countries and areas of WHO's Western Pacific Region | |
| P478 | volume | 8 | |